Literature DB >> 20717743

Biology and pathophysiology of the new human retrovirus XMRV and its association with human disease.

Alice Rusmevichientong1, Samson A Chow.   

Abstract

Xenotropic murine leukemia virus-related virus (XMRV) is a new human retrovirus originally identified in prostate cancer patients with a deficiency in the antiviral enzyme RNase L. XMRV has been detected with varying frequencies in cases of prostate cancer and chronic fatigue syndrome (CFS), as well as in a small proportion of healthy individuals. An etiologic link between XMRV infection and human disease, however, has yet to be established. Here, we summarize existing knowledge regarding the characteristics of XMRV replication, association of XMRV with prostate cancer and CFS, and potential mechanisms of XMRV pathophysiology. We also highlight several areas, such as the establishment of standardized assays and the development of animal models, as future directions to advance our current understanding of XMRV and its relevance to human disease.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20717743     DOI: 10.1007/s12026-010-8165-y

Source DB:  PubMed          Journal:  Immunol Res        ISSN: 0257-277X            Impact factor:   2.829


  102 in total

Review 1.  Rous-Whipple Award Lecture. Viruses, immunity, and cancer: lessons from hepatitis B.

Authors:  F V Chisari
Journal:  Am J Pathol       Date:  2000-04       Impact factor: 4.307

2.  Workgroup I: rodent models of prostate cancer.

Authors:  M S Lucia; D G Bostwick; M Bosland; A T Cockett; D W Knapp; I Leav; M Pollard; C Rinker-Schaeffer; T Shirai; B A Watkins
Journal:  Prostate       Date:  1998-06-15       Impact factor: 4.104

Review 3.  Internal transcriptional regulatory elements in HIV-1 and other retroviruses.

Authors:  E Verdin; C Van Lint
Journal:  Cell Mol Biol (Noisy-le-grand)       Date:  1995-05       Impact factor: 1.770

4.  XMRV infection in patients with prostate cancer: novel serologic assay and correlation with PCR and FISH.

Authors:  Rebecca S Arnold; Natalia V Makarova; Adeboye O Osunkoya; Suganthi Suppiah; Takara A Scott; Nicole A Johnson; Sushma M Bhosle; Dennis Liotta; Eric Hunter; Fray F Marshall; Hinh Ly; Ross J Molinaro; Jerry L Blackwell; John A Petros
Journal:  Urology       Date:  2010-04       Impact factor: 2.649

Review 5.  Retroviral insertional mutagenesis: tagging cancer pathways.

Authors:  Harald Mikkers; Anton Berns
Journal:  Adv Cancer Res       Date:  2003       Impact factor: 6.242

6.  Tetherin inhibits retrovirus release and is antagonized by HIV-1 Vpu.

Authors:  Stuart J D Neil; Trinity Zang; Paul D Bieniasz
Journal:  Nature       Date:  2008-01-16       Impact factor: 49.962

7.  A novel founder mutation in the RNASEL gene, 471delAAAG, is associated with prostate cancer in Ashkenazi Jews.

Authors:  Hanna Rennert; Dani Bercovich; Ayala Hubert; Dvora Abeliovich; Uri Rozovsky; Anat Bar-Shira; Sonya Soloviov; Letizia Schreiber; Haim Matzkin; Gad Rennert; Luna Kadouri; Tamar Peretz; Yuval Yaron; Avi Orr-Urtreger
Journal:  Am J Hum Genet       Date:  2002-07-23       Impact factor: 11.025

Review 8.  Chromosomal deletions and tumor suppressor genes in prostate cancer.

Authors:  J T Dong
Journal:  Cancer Metastasis Rev       Date:  2001       Impact factor: 9.264

9.  Failure to detect the novel retrovirus XMRV in chronic fatigue syndrome.

Authors:  Otto Erlwein; Steve Kaye; Myra O McClure; Jonathan Weber; Gillian Wills; David Collier; Simon Wessely; Anthony Cleare
Journal:  PLoS One       Date:  2010-01-06       Impact factor: 3.240

10.  Lack of evidence for xenotropic murine leukemia virus-related virus(XMRV) in German prostate cancer patients.

Authors:  Oliver Hohn; Hans Krause; Pia Barbarotto; Lars Niederstadt; Nadine Beimforde; Joachim Denner; Kurt Miller; Reinhard Kurth; Norbert Bannert
Journal:  Retrovirology       Date:  2009-10-16       Impact factor: 4.602

View more
  3 in total

1.  Analysis of single-nucleotide polymorphisms in patient-derived retrovirus integration sites reveals contamination from cell lines acutely infected by xenotropic murine leukemia virus-related virus.

Authors:  Alice Rusmevichientong; Jaydip Das Gupta; Petra S Elias; Robert H Silverman; Samson A Chow
Journal:  J Virol       Date:  2011-09-21       Impact factor: 5.103

Review 2.  Pathologic effects of RNase-L dysregulation in immunity and proliferative control.

Authors:  Heather J Ezelle; Bret A Hassel
Journal:  Front Biosci (Schol Ed)       Date:  2012-01-01

Review 3.  Complementary and alternative medicine for patients with chronic fatigue syndrome: a systematic review.

Authors:  Terje Alraek; Myeong Soo Lee; Tae-Young Choi; Huijuan Cao; Jianping Liu
Journal:  BMC Complement Altern Med       Date:  2011-10-07       Impact factor: 3.659

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.